Table 2.

BBN cross-validation results for each train-and-test pair and a posteriori testing results

	AUC		PV @ 50%		Cancer, At 50% Threshold		Benign, At 50% Threshold
	Benign	Cancer	Benign	Cancer	Sensitivity	Specificity	Sensitivity	Specificity
Test 1	71.4%	71.5%	60.0%	66.7%	66.8%	50.0%	60.0%	58.3%
Test 2	93.4%	93.4%	80.0%	81.8%	81.8%	70.0%	90.0%	81.7%
Test 3	89.2%	88.7%	81.3%	85.7%	66.8%	85.7%	92.9%	55.6%
Test 4	89.8%	89.1%	81.8%	66.7%	90.0%	69.2%	77.1%	80.0%
Test 5	92.1%	92.2%	77.8%	91.7%	92.4%	87.5%	87.6%	77.0%
Test 6	99.8%	99.8%	100.0%	100.0%	100.0%	91.6%	100.0%	77.8%
Test 7	76.0%	76.0%	80.0%	80.0%	90.0%	80.0%	80.0%	70.0%
Test 8	90.6%	90.5%	78.6%	85.7%	66.8%	83.3%	100.0%	33.3%
Test 9	89.8%	90.5%	80.0%	81.8%	81.8%	70.0%	90.0%	72.7%
Test 10	88.2%	88.2%	70.0%	91.7%	85.6%	87.5%	87.6%	28.6%
Mean	88.0%	88.0%	78.9%	83.2%	82.2%	77.5%	86.5%	63.5%
Internal	88.6%	89.0%	81.5%	82.6%	81.8%	81.3%	82.4%	81.0%